News PharmaBlock Sciences (Nanjing), Inc.

Equities

300725

CNE1000035K5

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
32.89 ^CNY	-1.94%		-5.73%	-16.25%

Apr. 23	PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmaBlock Proposes Final Dividend for 2023	Apr. 23	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.	Apr. 01	CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.	Apr. 01	CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.	Jan. 02	CI
PharmaBlock Sciences, Inc Opens HPAPI GMP Facility at Zhejiang Manufacturing Site	Dec. 26	CI
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component A Share Index	Dec. 11	CI
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component Index	Dec. 11	CI
PharmaBlock Sciences, Inc. announces an Equity Buyback for CNY 40 million worth of its shares.	23-10-30	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
PharmaBlock Sciences, Inc. authorizes a Buyback Plan.	23-10-29	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Pharmablock Sciences, Inc. Announces Final Dividend on Share A for 2022, Payable in June 13, 2023	23-06-06	CI
Pharmablock Sciences, Inc. Approves Election of Jie Yuanping and Wu Juanjuan as Non-Independent Directors	23-05-15	CI
Pharmablock Sciences, Inc. Approves Final Cash Dividend for the Year 2022	23-05-15	CI
PharmaBlock Sciences, Inc. Proposes Final Cash Dividend for the Year 2022	23-04-24	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
PharmaBlock Opens New R&D Facility in Pennsylvania	23-03-27	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PharmaBlock Sciences (Nanjing), Inc.

Equities

300725

CNE1000035K5

Summary

Filters